Lucid Diagnostics (NASDAQ:LUCD) just reported results for the first quarter of 2024.
- Lucid Diagnostics reported earnings per share of -21 cents. This was above the analyst estimate for EPS of -27 cents.
- The company reported revenue of $1.00 million.
- This was 4.67% worse than the analyst estimate for revenue of $1.05 million.